Optimal combination of immune cells for predicting outcomes in ESCC patients following neoadjuvant immunochemotherapy: Results from a prospective phase II trial

Genes & Diseases 2026 Open access

Read full text
Authors: Peipei Wang, Yueyun Chen, l Zhi-Bing Lu, Yue Zheng, Xia Liu, Haibo Mao, Zexin Yi, Jiajun Li, Qin Zhang, Chengwu Zeng, Yong Ming Wu, Zhenyu Ding
+1 more Cunte Chen
DOI: 10.1016/j.gendis.2026.102040
Cited by: 0
References: 5

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Esophageal Cancer Research and Treatment Inflammatory Biomarkers in Disease Prognosis

Publication details

Journal / source
Genes & Diseases
Volume
13
Issue
6
Pages
102040–102040
Publication date
18 January 2026
Language
EN